Kynurenine/Tryptophan Ratio in Major Depressive Disorder

Kynurenine/Tryptophan Ratio belongs to the endocrine group of Major Depressive Disorder markers and is reported to be raised relative to non-suicidal MDD patients. The cited literature links this alteration to suicidal behavior. The finding is drawn from Messaoud et al. 2022; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedEndocrine

Summary

Direction in Major Depressive Disorder↑ Elevated — higher than in the comparison group
CategoryEndocrine
Compared againstnon-suicidal MDD patients
Associated symptomssuicidal behavior
SourceMessaoud et al. 2022 — doi:10.2174/1568026621666210909160210
Condition atlasMajor Depressive Disorder Biomarker Atlas

Related Endocrine markers in Major Depressive Disorder

Full list: Major Depressive Disorder Biomarker Atlas.

Frequently asked questions

Is Kynurenine/Tryptophan Ratio high or low in Major Depressive Disorder?

Elevated. Studies summarised in the OSMF atlas report higher Kynurenine/Tryptophan Ratio in Major Depressive Disorder than in non-suicidal MDD patients. Source: Messaoud et al. 2022.

What symptoms is Kynurenine/Tryptophan Ratio associated with in Major Depressive Disorder?

The cited literature associates this marker with suicidal behavior. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Kynurenine/Tryptophan Ratio?

The atlas record does not list a standardised clinical test code (LOINC) for Kynurenine/Tryptophan Ratio, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal Kynurenine/Tryptophan Ratio result diagnostic of Major Depressive Disorder?

No. No single biomarker is diagnostic of Major Depressive Disorder. Kynurenine/Tryptophan Ratio findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Kynurenine/Tryptophan Ratio in Major Depressive Disorder: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 8, 2026, from https://research.opensourcemed.info/biomarkers/major-depressive-disorder/kynurenine-tryptophan-ratio.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-10-08 · Page generated from major-depressive-disorder.json · Browse: Major Depressive Disorder atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.